Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer’s dementia?
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer’s dementia? ; volume:10 ; number:1 ; day:2 ; month:10 ; year:2018 ; pages:1-6 ; date:12.2018
Alzheimer's research & therapy ; 10, Heft 1 (2.10.2018), 1-6, 12.2018
- Urheber
-
Crum, Jana
- Beteiligte Personen und Organisationen
-
Wilson, Jeffrey
Sabbagh, Marwan
SpringerLink (Online service)
- DOI
-
10.1186/s13195-018-0430-7
- URN
-
urn:nbn:de:101:1-2018111200362787638947
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Crum, Jana
- Wilson, Jeffrey
- Sabbagh, Marwan
- SpringerLink (Online service)
Ähnliche Objekte (12)
White matter hyperintensities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer’s disease
Pathological phenotypes of astrocytes in Alzheimer’s disease
Identification and validation of Alzheimer’s disease-related metabolic brain pattern in biomarker confirmed Alzheimer’s dementia patients
Retinal pathological features and proteome signatures of Alzheimer’s disease
Pathological Alterations Induced by intraneuronal Aβ in Alzheimer’s Disease
Alzheimer’s disease pathological lesions activate the spleen tyrosine kinase
Early-Stage MRI Volumetric Differences in White Matter Hyperintensity and Temporal Lobe Volumes between Autopsy-Confirmed Alzheimer’s Disease, Cerebral Small Vessel Disease, and Mixed Pathologies
Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer’s disease
Deep joint learning of pathological region localization and Alzheimer’s disease diagnosis
Tau in Alzheimer’s Disease: Pathological Alterations and an Attractive Therapeutic Target
The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
Plasma p-tau212 antemortem diagnostic performance and prediction of autopsy verification of Alzheimer’s disease neuropathology
White matter hyperintensities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer’s disease
Pathological phenotypes of astrocytes in Alzheimer’s disease
Identification and validation of Alzheimer’s disease-related metabolic brain pattern in biomarker confirmed Alzheimer’s dementia patients
Retinal pathological features and proteome signatures of Alzheimer’s disease
Pathological Alterations Induced by intraneuronal Aβ in Alzheimer’s Disease
Alzheimer’s disease pathological lesions activate the spleen tyrosine kinase
Early-Stage MRI Volumetric Differences in White Matter Hyperintensity and Temporal Lobe Volumes between Autopsy-Confirmed Alzheimer’s Disease, Cerebral Small Vessel Disease, and Mixed Pathologies
Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer’s disease
Deep joint learning of pathological region localization and Alzheimer’s disease diagnosis
Tau in Alzheimer’s Disease: Pathological Alterations and an Attractive Therapeutic Target
The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
Plasma p-tau212 antemortem diagnostic performance and prediction of autopsy verification of Alzheimer’s disease neuropathology
White matter hyperintensities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer’s disease
Pathological phenotypes of astrocytes in Alzheimer’s disease
Identification and validation of Alzheimer’s disease-related metabolic brain pattern in biomarker confirmed Alzheimer’s dementia patients
Retinal pathological features and proteome signatures of Alzheimer’s disease
Pathological Alterations Induced by intraneuronal Aβ in Alzheimer’s Disease
Alzheimer’s disease pathological lesions activate the spleen tyrosine kinase
Early-Stage MRI Volumetric Differences in White Matter Hyperintensity and Temporal Lobe Volumes between Autopsy-Confirmed Alzheimer’s Disease, Cerebral Small Vessel Disease, and Mixed Pathologies
Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer’s disease
Deep joint learning of pathological region localization and Alzheimer’s disease diagnosis
Tau in Alzheimer’s Disease: Pathological Alterations and an Attractive Therapeutic Target
The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases